Complete Wegovy Journey: One Pharmacy, Every Dose Stage
1.7 mg Wegovy to Mounjaro: Understanding Your Complete Dose Options
When comparing 1.7 mg Wegovy to Mounjaro, having access to every dose throughout your treatment journey makes all the difference. EverydayMeds stocks the complete Wegovy escalation pathway: 0.25mg starter doses through to 2.4mg maintenance, ensuring you never face supply disruption or need to find a new pharmacy mid-treatment. This comprehensive approach means patients starting at 0.25mg can progress seamlessly through 0.5mg, 1mg, 1.7mg, and finally 2.4mg maintenance without any supply concerns.
The 1.7mg dose represents weeks 13-16 of your Wegovy journey - the crucial penultimate stage where many patients experience accelerated results before reaching maintenance. At this point, you're likely seeing significant appetite suppression and may be considering whether Wegovy's GLP-1-only mechanism or Mounjaro's dual GIP+GLP-1 approach better suits your long-term goals. Having both options available from the same trusted pharmacy ensures continuity of care regardless of your prescriber's recommendation.
Wegovy Pricing Structure and Value Across All Dose Levels
Our 1.7mg Wegovy pens cost £139.99, positioning this dose competitively within the complete escalation pathway that starts at £79.99 for 0.25mg starters and progresses to £209.99 for 2.4mg maintenance. The Elevate Duo bundle combines 1.7mg and 2.4mg pens for £369.99, providing a seamless transition into maintenance dosing. Returning customers apply code DOSE25 at checkout to access these optimised prices, whilst new patients use FIRST40.
For patients preferring consistent dosing at 1.7mg, our Consistency bundle offers two 1.7mg pens for £309.99, supporting extended titration periods. The Progressive Trio (0.5mg, 1mg, 1.7mg) at £369.99 covers three critical escalation stages, whilst our Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99. This comprehensive pricing structure supports every treatment approach from conservative escalation to confident progression toward maintenance.
Clinical Evidence Supporting 1.7 mg Wegovy Versus Mounjaro Mechanisms
The STEP clinical trials demonstrated Wegovy's efficacy across its full dose range, with the 2.4mg maintenance dose showing approximately 15% average weight loss at 68 weeks when used alongside diet and exercise (Wilding et al., NEJM, 2021). The 1.7mg dose serves as the critical pre-maintenance stage where patients typically experience substantial appetite suppression before transitioning to their final therapeutic dose.
Mounjaro's SURMOUNT trials showed its dual GIP+GLP-1 receptor agonist mechanism may offer different benefits, though direct head-to-head comparisons aren't available due to different trial designs and populations. Both medications represent prescription-only approaches requiring clinical assessment and ongoing medical supervision throughout treatment.
How Wegovy's GLP-1 Mechanism Works at 1.7mg Dosing
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. At the 1.7mg dose level, patients typically experience pronounced appetite suppression and reduced food cravings as the medication works on brain appetite centres. The once-weekly FlexTouch pen delivers consistent therapeutic levels throughout the week, maintaining steady appetite control. This mechanism may help patients develop sustainable eating patterns that support long-term weight management goals. Clinical studies suggest the 1.7mg dose provides substantial therapeutic effect whilst serving as preparation for 2.4mg maintenance dosing.
Streamlined Ordering Process for Complete Dose Range
EverydayMeds' 3-minute online clinical assessment covers your complete treatment journey, whether you're starting at 0.25mg or progressing to 1.7mg and beyond. Our prescribers typically complete reviews within 3 working days (24-hour express option available), assessing your suitability for continued Wegovy treatment or potential transition to Mounjaro if clinically appropriate. Once approved, all doses ship via next-day delivery using cold-chain temperature-controlled packaging to maintain medication integrity. Our GPhC-registered pharmacy (#9012878) ensures every pen meets strict pharmaceutical standards from initial starter doses through maintenance treatment. This comprehensive service means one pharmacy relationship supports your entire weight management journey.
Storage and Practical Considerations for 1.7mg Treatment
Wegovy pens require refrigeration at 2-8°C before first use but offer superior travel flexibility with 6 weeks of room temperature stability below 30°C once removed from cold storage. This compares favourably to Mounjaro's 21-day room temperature limit, making Wegovy particularly suitable for patients with active lifestyles or frequent travel commitments. The FlexTouch pen design delivers precise 1.7mg doses with minimal injection discomfort, and the clear solution allows easy inspection for particles or discolouration. Proper dose escalation from 1mg to 1.7mg over 4-week periods helps minimise gastrointestinal side effects whilst building toward maintenance efficacy. Never skip dose levels or extend beyond prescribed intervals, as this may compromise both safety and effectiveness.
Why Complete Dose Availability Matters for 1.7 mg Wegovy to Mounjaro Decisions
Having every Wegovy dose readily available means your treatment decisions aren't limited by supply constraints or pharmacy capabilities. If your prescriber recommends staying with Wegovy through to 2.4mg maintenance, you're assured seamless progression without sourcing delays. Alternatively, if clinical assessment suggests Mounjaro's dual-action mechanism better suits your metabolism, you can transition confidently knowing both options remain available.
This complete inventory approach particularly benefits patients at the 1.7mg stage who may need flexible dosing strategies - some extend this dose for additional weeks, others progress rapidly to maintenance, and some may need to step back to 1mg temporarily. Having every option immediately available ensures your treatment adapts to your individual response rather than external supply limitations.
Secure Your Complete Treatment Pathway Today
Whether continuing with 1.7mg Wegovy or exploring Mounjaro alternatives, EverydayMeds provides the complete solution for your weight management journey. Use code DOSE25 at checkout for returning customer pricing, or FIRST40 for new patient assessment. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment and secure assured access to every dose level throughout your treatment. Our comprehensive inventory and expert prescriber support ensure you never compromise on treatment continuity or clinical outcomes. Start your assessment today and experience the confidence of complete dose availability from a trusted GPhC-registered pharmacy.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
